Beta-apo-8-carotenal
Overview
Beta-apo-8-carotenal is an orange-red carotenoid chemically related to beta-carotene (E160a). It occurs naturally in small amounts in spinach, citrus peel, and some other plants, but food-grade material is synthetically produced for consistency and cost. It is used as an orange-to-red colourant in beverages, cheese, margarines, and other fat-containing foods where its lipophilic nature ensures good distribution.
JECFA's ADI is 5 mg per kilogram body weight per day, established in 1974. Like other carotenoids, beta-apo-8-carotenal is converted in the intestinal wall and liver to retinol (vitamin A), contributing to vitamin A nutritional status. This pro-vitamin A activity is generally considered beneficial; however, very high intakes of preformed vitamin A can be toxic, so the ADI accounts for this pathway.
Beta-apo-8-carotenal is approved in the EU, and generally permitted in most global food markets. It carries a natural-origin positioning given its structural relationship to beta-carotene and its presence in food plants. There are no specific safety concerns for healthy adults at typical dietary exposures from food additive use. Pregnant women who are already supplementing vitamin A should note that cumulative intake from all vitamin A sources — including carotenoid food colours — contributes to total vitamin A status.
Generated from verified JECFA, EFSA, and regulatory data. All numerical values are sourced from the WHO/FAO JECFA Combined Compendium and EFSA OpenFoodTox 3.0.
Safety Assessment
| Body | Acceptable Daily Intake (ADI) | Year |
|---|---|---|
| JECFA | 0–5 mg/kg body weight/day · JECFA 1974 | 1974 |
| EFSA | — | — |
ADI = the amount of a substance a person can consume every day over a lifetime without appreciable health risk. Expressed as mg per kg body weight per day. Source: WHO/FAO JECFA Combined Compendium; EFSA OpenFoodTox 3.0.
Scientific Notes
Orange-red carotenoid; structurally related to beta-carotene. Metabolised to retinol and used as a source of vitamin A activity.